Pricing

Agios Pharmaceuticals Inc (AGIO)

followers ·
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Brian M. Goff
Employees: 390
Web site: agios.com
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
617-649-8600
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Agios Pharmaceuticals, Inc. engages in the discovery and development of medicines in the field of cellular metaboli® and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes. AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications.
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available